| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 21, 2020 | 27.0999 | 27.0999 | 25.60 | 25.80 | 2,958,926 |
| Feb 20, 2020 | 28.73 | 28.73 | 26.60 | 26.70 | 1,871,155 |
| Feb 19, 2020 | 27.76 | 29.20 | 27.76 | 28.00 | 2,172,422 |
| Feb 18, 2020 | 26.109 | 28.00 | 26.109 | 27.80 | 3,077,830 |
| Feb 17, 2020 | 24.00 | 26.80 | 24.00 | 26.60 | 5,016,566 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 15,000 | Prev Close | 25.80 |
| Shares in Issue (m) | 375.20 | Market Cap (£m) | 105.06 |
| PE Ratio | -0.82 | Div per Share () | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -34.00 | EPS Growth (%) | -9.68 |
| PEG | 0.08 | DPS Growth (%) | n/a |
| ROCE | -30.49 | Net Gearing | 45.80 |
| Quick Ratio | 0.40 | Current Ratio | 0.43 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 13 Feb | Peel Hunt | Buy | 25.80 | 60.00 | - | Reiterates |
| 05 Feb | Peel Hunt | Buy | 25.80 | 60.00 | - | Reiterates |
| 27 Jan | Peel Hunt | Buy | 25.80 | 60.00 | - | Reiterates |
| 10 Jan | Peel Hunt | Buy | 25.80 | 70.00 | - | Reiterates |
| 09 Jan | Peel Hunt | Buy | 25.80 | 70.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 06 Dec 2019 | Garry Watts | Buy | 477,340 @ 21.0p | £100,241.40 |
| 01 Oct 2019 | Jonathan Emms | Buy | 300,000 @ 16.5p | £49,500.00 |
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
You can opt out at any time.
